Skip to main content
Công ty Cổ phần Dược phẩm OPC logo

Công ty Cổ phần Dược phẩm OPC — Investor Relations & Filings

Ticker · OPC ISIN · VN000000OPC9 HSX Manufacturing
Open in API
Filings indexed 278 across all filing types
Latest filing 2026-04-29 Board/Management Inform…
Country VN Viet Nam
Listing HSX OPC

About Công ty Cổ phần Dược phẩm OPC

http://www.opcpharma.com

OPC Pharmaceutical Joint Stock Company, established in 1977, is a prominent pharmaceutical manufacturer focused on herbal medicines. With nearly five decades of experience, OPC specializes in the research, development, and production of pharmaceuticals derived from Vietnamese medicinal herbs, integrating advanced extraction technologies. The company manages GACP-WHO certified raw material cultivation areas and operates GMP-WHO compliant manufacturing facilities, ensuring stringent quality control. OPC's product portfolio includes pharmaceuticals, antiseptics, and disinfectants. The company aims to elevate the quality of Vietnamese herbal products to international standards, supported by a strong commitment to quality assurance and a history of industry recognition.

Recent filings

Filing Released Lang Actions
OPC: Nghị quyết HĐQT về việc bầu Chủ tịch HĐQT nhiệm kỳ 2026-2031
Board/Management Information Classification · 85% confidence The document is a formal Board of Directors resolution (“Nghị quyết của Hội đồng quản trị”) appointing a new Chairman for the 2026–2031 term. It announces a change in the company’s board leadership, fitting precisely under board/management changes.
2026-04-29 Vietnamese
OPC: Giải trình biến động KQKD quý 1/2026 so với cùng kỳ năm trước
Regulatory Filings Classification · 87% confidence The document is a brief, stock-exchange submission titled “Giải trình biến động kết quả kinh doanh” (Explanation of fluctuations in business results) showing only Q1/2026 vs Q1/2025 revenue and profit with a short commentary. It does not contain full interim financial statements or analysis, nor is it the full quarterly report. It is a regulatory explanation filing to the Ho Chi Minh City Stock Exchange, fitting the general “Regulatory Filings” category (RNS) as a required compliance announcement rather than a standalone interim report or earnings release.
2026-04-29 Vietnamese
OPC: Thông báo thay đổi nhân sự
Board/Management Information Classification · 92% confidence The document is headed “THÔNG BÁO THAY ĐỔI NHÂN SỰ” (Change in Personnel) and addressed to the stock exchange, detailing appointments and resignations of board and supervisory members, with effective dates and profiles (Appendix III). This is a clear announcement of changes to the company’s board of directors and senior management, matching the “Board/Management Information” category.
2026-04-28 Vietnamese
OPC: Biên bản họp và Nghị quyết ĐHĐCĐ thường niên năm 2026
AGM Information Classification · 82% confidence The document is the detailed minutes (“biên bản”) of the company’s 2026 Annual General Meeting of Shareholders, including attendance lists, agenda items, presentations of various reports, and voting results for each resolution. This corresponds to AGM Information, as it documents the materials and proceedings of the AGM itself, rather than merely announcing results or filing a financial report.
2026-04-28 Vietnamese
OPC: Đính chính số liệu BCTC riêng năm 2025
Regulatory Filings Classification · 87% confidence The document is a formal correction notice and confirmation letter regarding adjustments to the previously issued audited separate financial statements for the year ended 31 December 2025. It does not contain the full financial statements themselves, nor is it the primary audited report; rather, it is an auditor’s confirmation and attestation letter confirming the company’s correction. According to the certification rule, a document that is primarily an auditor certification or attestation—even if it references a specific report—should be classified as a general regulatory filing. Therefore, this should be classified as Regulatory Filings (RNS).
2026-04-24 Vietnamese
OPC: Báo cáo thường niên năm 2025
Annual Report Classification · 95% confidence The document is titled “Báo cáo thường niên 2025” (Annual Report 2025) of OPC Pharmaceutical JSC. It contains full sections typical of an annual report—vision & mission, Board of Directors’ evaluation, management review, business activities, corporate governance, financial statements, and detailed narrative on performance. It is a substantive, standalone yearly report, not merely an announcement or proxy, so it fits the Annual Report category. FY 2025
2026-04-14 Vietnamese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.